» Articles » PMID: 38158464

Exploring the Role of Wnt Ligands in Osteogenic Differentiation of Human Periodontal Ligament Stem Cells

Overview
Specialty Dentistry
Date 2023 Dec 29
PMID 38158464
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: This study aimed to investigate the functions of 19 types of Wnt ligands during the process of osteogenic differentiation in human periodontal ligament stem cells (hPDLSCs), with particular attention to WNT3A and WNT4.

Materials And Methods: The expression levels of 19 types of Wnt ligands were examined using real-time quantitative polymerase chain reaction (real-time qPCR) during hPDLSCs osteogenic differentiation at 7, 10, and 14 days. Knockdown of WNT3A and WNT4 expression was achieved using adenovirus vectors, and conditioned medium derived from WNT3A and WNT4 overexpression plasmids was employed to investigate their roles in hPDLSCs osteogenesis. Osteogenic-specific genes were analyzed using real-time qPCR. Alkaline phosphatase (ALP) and alizarin red S activities and staining were employed to assess hPDLSCs' osteogenic differentiation ability.

Results: During hPDLSCs osteogenic differentiation, the expression of 19 types of Wnt ligands varied, with WNT3A and WNT4 showing significant upregulation. Inhibiting WNT3A and WNT4 expression hindered hPDLSCs' osteogenic capacity. Conditioned medium of WNT3A promoted early osteogenic differentiation, while WNT4 facilitated late osteogenesis slightly.

Conclusion: Wnt ligands, particularly WNT3A and WNT4, play an important role in hPDLSCs' osteogenic differentiation, highlighting their potential as promoters of osteogenesis.

Clinical Relevance: Given the challenging nature of alveolar bone regeneration, therapeutic strategies that target WNT3A and WNT4 signaling pathways offer promising opportunities. Additionally, innovative gene therapy approaches aimed at regulating of WNT3A and WNT4 expression hold potential for improving alveolar bone regeneration outcomes.

References
1.
Li Y, Ling J, Jiang Q . Inflammasomes in Alveolar Bone Loss. Front Immunol. 2021; 12:691013. PMC: 8221428. DOI: 10.3389/fimmu.2021.691013. View

2.
Ketharanathan V, Torgersen G, Petrovski B, Preus H . Radiographic alveolar bone level and levels of serum 25-OH-Vitamin D in ethnic Norwegian and Tamil periodontitis patients and their periodontally healthy controls. BMC Oral Health. 2019; 19(1):83. PMC: 6518642. DOI: 10.1186/s12903-019-0769-6. View

3.
Zhao J, Zhou Y, Zhao Y, Gao Z, Ouyang Z, Ye Q . Oral cavity-derived stem cells and preclinical models of jaw-bone defects for bone tissue engineering. Stem Cell Res Ther. 2023; 14(1):39. PMC: 10022059. DOI: 10.1186/s13287-023-03265-z. View

4.
Seo B, Miura M, Gronthos S, Bartold P, Batouli S, Brahim J . Investigation of multipotent postnatal stem cells from human periodontal ligament. Lancet. 2004; 364(9429):149-55. DOI: 10.1016/S0140-6736(04)16627-0. View

5.
Kuberan S, Ravi M, Manjappa A, Rao S, Basavarajappa M, Shetty V . Assessment of proliferation, clonogenic assay, and osteogenic differentiation of human periodontal ligament stem cells following application of orthodontic forces. Indian J Dent Res. 2023; 33(4):382-387. DOI: 10.4103/ijdr.ijdr_554_22. View